Situation
At the peak of the COVID-19 pandemic, the UMASS Memorial DCU Field Hospital was created to provide care for acute COVID-19 patients who did not need intensive care. Since its inception, the Field Hospital has admitted over six hundred patients.
Throughout this time, staff providing patient care worked in areas with a high presence of SARS-CoV-2 in the environment. Based on infection control practices, air lock systems are designed to contain in-air pathogens from escaping containment areas; however, without an in-air pathogen surveillance solution, quantitative metrics are not available. This means that the proper functionality of air lock systems cannot be verified.
Get insight into in-air pathogen presence to monitor and improve safety protocols
Complement individual screening programs
Identify risk to help safely re-open and stay open
Invest in a solution that’s easy to use with minimal training
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com.